MOR Annual SG&A
$100.18 M
+$5.03 M+5.29%
31 December 2023
Summary:
As of February 3, 2025, MOR annual selling, general & administrative expenses is $100.18 million, with the most recent change of +$5.03 million (+5.29%) on December 31, 2023. During the last 3 years, it has fallen by -$333.00 thousand (-0.33%).MOR Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MOR Quarterly SG&A
-$9.87 M
-$47.87 M-125.97%
31 December 2023
Summary:
As of February 3, 2025, MOR quarterly selling, general & administrative expenses is -$9.87 million, with the most recent change of -$47.87 million (-125.97%) on December 31, 2023. Over the past year, it has increased by +$12.40 million (+55.69%).MOR Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MOR TTM SG&A
-$3.09 B
0.00%
31 December 2023
Summary:
As of February 3, 2025, MOR TTM selling, general & administrative expenses is -$3.09 billionOver the past year, it has dropped by -$3.19 billion (-3291.18%).MOR TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MOR Selling, General & Administrative Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +5.3% | +55.7% | -3291.2% |
3 y3 years | -0.3% | +65.8% | -3255.0% |
5 y5 years | +199.7% | +65.8% | -3255.0% |
MOR Selling, General & Administrative Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | -18.7% | -113.9% | -2165.0% |
MorphoSys AG Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | $100.18 M(+5.3%) | -$9.87 M(-126.0%) | $100.48 M(+14.1%) |
Sept 2023 | - | $38.00 M(-10.6%) | $88.08 M(-1.6%) |
June 2023 | - | $42.53 M(+42.6%) | $89.47 M(+4.4%) |
Mar 2023 | - | $29.82 M(-233.9%) | $85.70 M(-11.5%) |
Dec 2022 | $95.15 M(-22.8%) | -$22.27 M(-156.5%) | $96.82 M(+43.0%) |
Sept 2022 | - | $39.39 M(+1.6%) | $67.72 M(-24.3%) |
June 2022 | - | $38.76 M(-5.3%) | $89.41 M(-26.5%) |
Mar 2022 | - | $40.94 M(-179.7%) | $121.70 M(-4.2%) |
Dec 2021 | $123.27 M(+22.6%) | -$51.36 M(-184.1%) | $127.06 M(-15.1%) |
Sept 2021 | - | $61.08 M(-14.0%) | $149.62 M(+5.0%) |
June 2021 | - | $71.05 M(+53.5%) | $142.49 M(+19.8%) |
Mar 2021 | - | $46.30 M(-260.7%) | $118.90 M(+21.4%) |
Dec 2020 | $100.52 M(+96.8%) | -$28.80 M(-153.4%) | $97.93 M(-31.1%) |
Sept 2020 | - | $53.94 M(+13.6%) | $142.15 M(+37.8%) |
June 2020 | - | $47.47 M(+87.4%) | $103.15 M(+52.4%) |
Mar 2020 | - | $25.33 M(+64.3%) | $67.69 M(+32.8%) |
Dec 2019 | $51.09 M(+52.8%) | $15.41 M(+3.2%) | $50.98 M(+7.9%) |
Sept 2019 | - | $14.94 M(+24.5%) | $47.27 M(+18.8%) |
June 2019 | - | $12.00 M(+39.2%) | $39.79 M(+10.4%) |
Mar 2019 | - | $8.63 M(-26.3%) | $36.05 M(+8.5%) |
Dec 2018 | $33.43 M(+43.8%) | $11.70 M(+56.8%) | $33.22 M(+11.0%) |
Sept 2018 | - | $7.46 M(-9.7%) | $29.94 M(+7.9%) |
June 2018 | - | $8.27 M(+42.6%) | $27.74 M(+11.4%) |
Mar 2018 | - | $5.80 M(-31.1%) | $24.91 M(+6.7%) |
Dec 2017 | $23.25 M(+32.3%) | $8.41 M(+59.8%) | $23.34 M(+11.5%) |
Sept 2017 | - | $5.27 M(-3.1%) | $20.93 M(+7.5%) |
June 2017 | - | $5.43 M(+28.4%) | $19.48 M(+7.1%) |
Mar 2017 | - | $4.23 M(-29.5%) | $18.19 M(+3.8%) |
Dec 2016 | $17.57 M(+51.8%) | $6.00 M(+57.4%) | $17.52 M(+53.9%) |
Sept 2016 | - | $3.81 M(-8.0%) | $11.38 M(-1.2%) |
June 2016 | - | $4.14 M(+16.4%) | $11.52 M(-2.5%) |
Mar 2016 | - | $3.56 M(-2726.5%) | $11.81 M(+1.7%) |
Dec 2015 | $11.58 M | -$135.60 K(-103.4%) | $11.62 M(+6.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2015 | - | $3.95 M(-10.9%) | $10.93 M(-7.0%) |
June 2015 | - | $4.43 M(+31.6%) | $11.75 M(-2.3%) |
Mar 2015 | - | $3.37 M(-508.4%) | $12.02 M(-8.9%) |
Dec 2014 | $12.88 M(-14.2%) | -$824.90 K(-117.3%) | $13.20 M(+15.9%) |
Sept 2014 | - | $4.78 M(+1.5%) | $11.39 M(-12.4%) |
June 2014 | - | $4.71 M(+3.6%) | $13.01 M(-11.1%) |
Mar 2014 | - | $4.54 M(-272.4%) | $14.63 M(-1.2%) |
Dec 2013 | $15.02 M(+56.2%) | -$2.64 M(-141.2%) | $14.81 M(-7.3%) |
Sept 2013 | - | $6.39 M(+0.9%) | $15.98 M(+19.7%) |
June 2013 | - | $6.33 M(+34.3%) | $13.35 M(+21.8%) |
Mar 2013 | - | $4.72 M(-421.7%) | $10.96 M(+14.7%) |
Dec 2012 | $9.62 M(-53.8%) | -$1.47 M(-138.9%) | $9.56 M(+12.0%) |
Sept 2012 | - | $3.77 M(-4.4%) | $8.54 M(-30.2%) |
June 2012 | - | $3.94 M(+19.0%) | $12.23 M(-28.8%) |
Mar 2012 | - | $3.31 M(-233.2%) | $17.19 M(-18.7%) |
Dec 2011 | $20.82 M(-32.4%) | -$2.49 M(-133.3%) | $21.15 M(-34.6%) |
Sept 2011 | - | $7.47 M(-16.1%) | $32.33 M(-0.7%) |
June 2011 | - | $8.90 M(+22.4%) | $32.55 M(+4.0%) |
Mar 2011 | - | $7.27 M(-16.3%) | $31.30 M(+1.8%) |
Dec 2010 | $30.79 M(-7.7%) | $8.69 M(+12.9%) | $30.76 M(-10.0%) |
Sept 2010 | - | $7.69 M(+0.6%) | $34.17 M(-1.4%) |
June 2010 | - | $7.65 M(+13.7%) | $34.66 M(+1.5%) |
Mar 2010 | - | $6.73 M(-44.4%) | $34.14 M(+1.5%) |
Dec 2009 | $33.34 M(+10.9%) | $12.10 M(+47.8%) | $33.64 M(+56.2%) |
Sept 2009 | - | $8.19 M(+15.0%) | $21.54 M(+61.3%) |
June 2009 | - | $7.12 M(+14.3%) | $13.35 M(+114.3%) |
Mar 2009 | - | $6.23 M | $6.23 M |
Dec 2008 | $30.07 M(-11.4%) | - | - |
Dec 2007 | $33.94 M(-226.1%) | - | - |
Dec 2006 | -$26.92 M(+114.7%) | - | - |
Dec 2005 | -$12.53 M(-234.0%) | - | - |
Dec 2004 | $9.36 M(+14.7%) | - | - |
Dec 2003 | $8.15 M(-54.0%) | - | - |
Dec 2002 | $17.73 M | - | - |
FAQ
- What is MorphoSys AG annual selling, general & administrative expenses?
- What is the all time high annual SG&A for MorphoSys AG?
- What is MorphoSys AG annual SG&A year-on-year change?
- What is MorphoSys AG quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for MorphoSys AG?
- What is MorphoSys AG quarterly SG&A year-on-year change?
- What is MorphoSys AG TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for MorphoSys AG?
- What is MorphoSys AG TTM SG&A year-on-year change?
What is MorphoSys AG annual selling, general & administrative expenses?
The current annual SG&A of MOR is $100.18 M
What is the all time high annual SG&A for MorphoSys AG?
MorphoSys AG all-time high annual selling, general & administrative expenses is $123.27 M
What is MorphoSys AG annual SG&A year-on-year change?
Over the past year, MOR annual selling, general & administrative expenses has changed by +$5.03 M (+5.29%)
What is MorphoSys AG quarterly selling, general & administrative expenses?
The current quarterly SG&A of MOR is -$9.87 M
What is the all time high quarterly SG&A for MorphoSys AG?
MorphoSys AG all-time high quarterly selling, general & administrative expenses is $71.05 M
What is MorphoSys AG quarterly SG&A year-on-year change?
Over the past year, MOR quarterly selling, general & administrative expenses has changed by +$12.40 M (+55.69%)
What is MorphoSys AG TTM selling, general & administrative expenses?
The current TTM SG&A of MOR is -$3.09 B
What is the all time high TTM SG&A for MorphoSys AG?
MorphoSys AG all-time high TTM selling, general & administrative expenses is $149.62 M
What is MorphoSys AG TTM SG&A year-on-year change?
Over the past year, MOR TTM selling, general & administrative expenses has changed by -$3.19 B (-3291.18%)